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We report a case series of patients with prolonged but reversible unconsciousness after coro-
navirus disease 2019 (COVID-19)–related severe respiratory failure.
Methods
A case series of patients who were admitted to the intensive care unit due to COVID-19–related
acute respiratory failure is described.
Results
After cessation of sedatives, the described cases all showed a prolonged comatose state. Di-
agnostic neurologic workup did not show signs of devastating brain injury. The clinical pattern
of awakening started with early eye opening without obeying commands and persistent flaccid
weakness in all cases. Time between cessation of sedatives to the first moment of being fully
responsive with obeying commands ranged from 8 to 31 days.
Conclusion
Prolonged unconsciousness in patients with severe respiratory failure due to COVID-19 can be
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In patients with coronavirus disease 2019 (COVID-19) who
are admitted to the intensive care unit (ICU) for respiratory
distress, an encephalopathy, most notably in the form of de-
lirium, occurs in up to 84%.1 Brain MRI studies in patients in
the ICU with COVID-19, including those with prolonged
comatose state, reported varying degrees of MRI abnormali-
ties, although few to no details were reported on the clinical
picture, course, and prognosis of prolonged unconsciousness
in such patients.2 Here, we report a case series of patients with
COVID-19 admitted to the ICU for respiratory failure who,
after cessation of sedatives, remained unconscious for longer
than expected periods. We describe how the protracted re-
covery of unconsciousness followed a similar clinical se-
quence. Because the world is still dealing with this spreading
pandemic, this finding has important implications for the
consulting neurologists trying to evaluate and prognosticate
patients with COVID-19 with unconsciousness after pro-
longed periods of mechanical ventilation in the ICU.
Methods
This is a multicenter case series of patients with severe respiratory
failure due to COVID-19 with prolonged unconsciousness after
cessation of sedatives. The case of 1 patient is provided, and
characteristics of 6 cases with a similar clinical pattern are sum-
marized in table 1 and supplementary table e-1 (available on
Dryad, doi.org/10.5061/dryad.866t1g1pb).
Standard Protocol Approvals, Registrations,
and Patient Consents
Informed consent was obtained from the patient described in
detail.
Data Availability
Additional anonymized data not available within the article or
supplementary material are available to qualified researchers
on reasonable request.
Patient 1
A 41-year-old woman with a medical history of diabetes mel-
litus, hypothyroidism, and severe obesity (body mass index
43.5 kg/m2) presented to the emergency department with a
3-day history of respiratory symptoms and bilateral infiltrates
on her chest x-ray. She tested positive on the oropharyngeal
swab test for severe acute respiratory syndrome coronavirus 2.
She was admitted to the hospital for oxygen therapy. Two days
later, she was transferred to the ICU due to worsening of
respiratory status and was intubated the same day. She de-
veloped an acute kidney injury necessitating dialysis from day 3
until ICU day 28. She was ventilated in the prone position for
the first 7 ICU days and subsequently in the supine position.
She had been on high-dose sedatives since intubation. The
sedative midazolam was stopped on ICU day 10, and the
sedative propofol was stopped on ICU day 14. She started
opening her eyes to stimuli without other motor reactions 2
days later and did not show any signs of a higher level of
consciousness (did not follow objects or persons with her eyes
and did not obey commands). She subsequently developed
several episodes of high fever with constantly negative blood
and sputum cultures with improving infection parameters (C-
reactive protein, ferritin, procalcitonin, cell counts) and was
treated with antibiotics. Because her consciousness level did
not improve beyond opening of her eyes, the concentrations of
midazolam and its metabolites were measured and were un-
detectable in blood on ICU day 18. She had been on thyroid
supplementary medication during her entire ICU stay, and free
thyroxine levels were measured within normal range several
times. Ancillary investigations (table 1) showed a severe critical
illness polyneuropathy. A brain MRI was subsequently per-
formed on ICU day 26, which showed a diffuse white matter
abnormalities (figure). Due to her sustained low level of con-
sciousness and MRI abnormalities, there was doubt about an
unfavorable prognosis, and discontinuation of further medical
treatment was discussed within the treating team. Follow-up
brain MRIs performed on ICU days 33 and 41 showed a
slightly improved picture of the diffuse white matter abnor-
malities, while newly developed restricted diffusion was noted
in the basal ganglia (figure). Fourteen days after the sedatives
were stopped, she started following people with her eyes for the
first time. During the following weeks, her level of conscious-
ness improved, and she eventually started obeying commands
adequately with her eyes and facial musculature in combination
with a flaccid tetraparesis. She started to move her fingers for
the first time on ICU day 63.
Tables 1 and 2 and supplementary table e-1 (available on
Dryad, doi.org/10.5061/dryad.866t1g1pb) show the charac-
teristics of 6 patients. All were admitted to the ICU for me-
chanical ventilation and were free of neurologic symptoms at
time of ICU admission. Patients were sedated between 14 and
31 days and showed prolonged unconsciousness after the
sedatives were stopped. The clinical pattern from un-
consciousness to awakening occurred in a similar sequence in
all patients. The first feature was opening of the eyes after
acoustic or tactile stimuli within 1 to 12 days after sedatives
were stopped. This eye opening was not accompanied by any
other motor reactions, making any contact, or following ob-
jects. Next, 5 to 12 days later, all patients started to follow
objects spontaneously with their eyes, which was still not
accompanied by obeying commands. At this stage, all patients
had a flaccid tetraparesis, areflexia, and no motor reactions to
painful stimuli. Subsequently, 1 to 17 days later, patients
Glossary
COVID-19 = coronavirus disease 2019; ICU = intensive care unit.
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started to obey commands for the first time, which always
began with facial musculature such as closing and opening of
the eyes or mouth. Motor reactions with the limbs occurred in
the last phase. All patients had a flaccid paralysis after awak-
ening that remained present for the recorded days in the ICU
or resolved only very slowly. In 5 of the 6 patients, a mixed or
hypoactive delirium was diagnosed after recovery of the
unconsciousness.
Discussion
In this case series, prolonged level of unconsciousness with full
recovery of the unconsciousness in patients with severe COVID-
19 is shown. The brain imaging abnormalities found in our
described case and other patients within our series are in line
with recently reported series of brain imaging in patients with
COVID-19 and a postmortem neuropathologic analysis,
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showing microbleeds and white matter abnormalities in varying
degrees.2,3 Some of these abnormalities have also been reported
previously in other critical illnesses, including a prolonged re-
versible comatose state in a case of sepsis.4–6 The main differ-
ential diagnosis in our case was a persistent comatose state due to
parainfectious autoimmune-mediated encephalitis or critical
illness–related encephalopathy. The clinical course in our case
series, normal CSF analyses, and spontaneous improvement
without any corticosteroids most likely support a critical
illness–related encephalopathy, although a clear distinction is
difficult to make. A long ICU course in severe COVID-19 is not
unusual. Due to the use of sedatives and muscle relaxants during
longer periods in patients with COVID-19 admitted to the ICU,
such patients often develop a severe form of ICU-acquired
weakness. Factors such a long use of sedatives and the presence
of severe generalized muscle weakness (present in all our cases)
complicate assessment of the level of consciousness.
In all of our patients, a similar clinical pattern was observed
during recovery of their unconsciousness. Opening of the eyes
occurred in the first week after sedatives were stopped in 5 of
the 6 patients without any other motor reactions with gener-
alized flaccid paralysis. This was followed by visual tracking of
people within 2 weeks after cessation of sedatives. Obeying
commands (mostly through facial musculature) occurred be-
tween 8 and 31 days after cessation of sedatives. This pattern of
awakening did not fit the regular patterns seen in patients in the
ICU in whom eye opening is frequently accompanied or
quickly followed by motor reactions to (painful) stimuli and an
encephalopathy with an active delirium, as was also shown in
the great majority of patients with COVID-19 in the ICU.1 Our
findings corroborate a recent case report showing intact func-
tional connectivity in the default mode network using fMRI in a
patient with prolonged unconsciousness admitted to the ICU
for respiratory failure due to COVID-19.7 One of the main
drawbacks of our study is the selection bias that is inherent to
case series. Although the patients recovered from their pro-
longed unconscious state, it is likely that long-term cognitive or
physical deficits remain present, in line with many reports on
long-term outcomes in patients with COVID-19.
Neurologists are frequently consulted due to neurologic symp-
tomatology in patients with COVID-19. As our case series
shows, it is conceivable that neurologists could be faced with the
dilemma to prognosticate on the basis of a prolonged state of
unconsciousness, all with the background of a pandemic with the
Figure Serial Brain MRIs in Presented Case
Diffuse leukoencephalopathy with restricted diffusion in the corona radiata and subcortical white matter on the first MRI slightly decreased on follow-up
MRIs. Newly developed restricted diffusion of the globus pallidus and substantia nigra was seen on the second and third MRIs. No signs of hemorrhages,
territorial infarcts, or microbleeds were seen.
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need for ICU capacity exceeding available resources. It is im-
portant to take into account the possible reversibility of pro-
longed unconsciousness in patients with COVID-19 admitted to
the ICU, which warrants watchful waiting in such cases.
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Table 2 Ancillary Neurologic Workup































Brain CT Unremarkable Small
intraventricular
bleeding












Brain MRI NA NA
Microbleeds − + − +
Leukoence
phalopathy
+ + + −
Infarcts − − − −
Abbreviations: NA = not available; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.
a Apart from normal cultures, additional molecular panel on CSF included adenovirus/enterovirus/herpes simplex virus 1 and 2, Hemophilus influenzae,
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